World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
7007
World Ranking
4890
National Ranking
409

Overview

Ian D. Poulton is affiliated with the University of Oxford in the United Kingdom and has contributed to research primarily in the fields of Medicine and Immunology and Microbiology. Their work spans several subfields, including Public Health, Environmental and Occupational Health, Infectious Diseases, Immunology, Epidemiology, and Molecular Biology.

The scientist's research covers a range of topics such as Malaria Research and Control, Mosquito-borne diseases and control, Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Complement system in diseases, vaccines and immunoinformatics approaches, and Viral Infections and Outbreaks Research.

Key recent publications include:

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial, 2020, Nature Medicine
  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses, 2020, Nature Medicine
  • Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial, 2020, The Lancet Infectious Diseases
  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination, 2021, Med
  • Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial, 2022, EBioMedicine

Frequent co-authors of Ian D. Poulton include:

  • Alison M. Lawrie
  • Adrian V. S. Hill
  • Megan Baker
  • Nick J. Edwards
  • Angela M. Minassian

The scientist's work is often published in specific venues such as:

  • The Lancet Microbe
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Medicine
  • The Lancet Infectious Diseases
  • Nature Communications

Best Publications

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins

  • Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

    Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

    Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  • ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Prateek Choudhary

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.

    Pedro M. Folegatti;Mustapha Bittaye;Amy Flaxman;Fernando Ramos Lopez

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).

    Amy Flaxman;Natalie G Marchevsky;Daniel Jenkin;Jeremy Aboagye

  • Phase Ia Clinical Evaluation of the Plasmodium Falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Katharine A Collins

  • Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

    Susanne H. Sheehy;Christopher J. A. Duncan;Sean C. Elias;Sumi Biswas

  • Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts.

    Thomas S. Churcher;Robert E. Sinden;Robert E. Sinden;Nick J. Edwards;Ian D. Poulton

  • Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

    Ruth O. Payne;Sarah E. Silk;Sean C. Elias;Kazutoyo Miura

  • Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

    Susanne H. Hodgson;Katie J. Ewer;Carly M. Bliss;Nick J. Edwards

  • Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals

    Clare R. Sander;Ansar A. Pathan;Natalie E. R. Beveridge;Ian Poulton

  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

    Angela M. Minassian;Sarah E. Silk;Jordan R. Barrett;Carolyn M. Nielsen

  • Demonstration of the blood-stage plasmodium falciparum controlled human malaria infection model to assess efficacy of the p. falciparum apical membrane antigen 1 Vaccine, FMP2.1/AS01

    Ruth O. Payne;Kathryn H. Milne;Sean C. Elias;Nick J. Edwards

  • Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial

    Unknown

  • Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

    Fiona M. Thompson;David W. Porter;Shinji L. Okitsu;Nicole Westerfeld

  • A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin

    Angela M. Minassian;Iman Satti;Ian D. Poulton;Joel Meyer

  • Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAPAgainst Controlled Human Malaria Infection in Malaria-Naive Individuals

    Susanne H. Hodgson;Katie J. Ewer;Carly M. Bliss;Nick J. Edwards

Frequent Co-Authors

Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford
Robert E. Sinden
Robert E. Sinden Imperial College London
Simon J. Draper
Simon J. Draper University of Oxford
Helen McShane
Helen McShane University of Oxford
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust
Daniel B. Wright
Daniel B. Wright University of Nevada, Las Vegas
Susanna Dunachie
Susanna Dunachie University of Oxford
Kazutoyo Miura
Kazutoyo Miura National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with advanced nursing roles, particularly in specialized areas like family and psychiatric mental health. For those interested in expanding their qualifications, finding the easiest fnp program can provide a more accessible pathway to becoming a Family Nurse Practitioner, which complements immunology expertise in patient care.

For nurses aiming to specialize further, programs like the top pmhnp programs offer excellent clinical placements that are crucial for gaining hands-on experience in psychiatric mental health, a field closely related to immunological disorders linked to mental health conditions.

Cost can be a barrier, but affordable options such as the cheapest online pmhnp certificate programs make advanced practice accessible without compromising quality. These programs help professionals build a strong foundation in both psychiatric care and immunological aspects of mental health.

Finally, understanding financial incentives is essential. Transparent information like the dnp salary transparency offers insights into expected salaries of Doctor of Nursing Practice graduates nationwide, helping prospective students make informed decisions about their education and career pathways.

Best Scientists Citing Ian D. Poulton

Trending Scientists